{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:59:24Z","timestamp":1767855564507,"version":"3.49.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bestpracticeobgyn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.bpobgyn.2014.05.008","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T18:53:17Z","timestamp":1401994397000},"page":"845-857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Male contraception"],"prefix":"10.1016","volume":"28","author":[{"given":"Jing","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie T.","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2014.05.008_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/humrep\/deh574","article-title":"Attitudes toward male fertility control: results of a multinational survey on four continents","volume":"20","author":"Heinemann","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/humrep\/15.3.646","article-title":"Would women trust their partners to use a male pill?","volume":"15","author":"Glasier","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/humrep\/15.3.637","article-title":"Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations","volume":"15","author":"Martin","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/er.2007-0041","article-title":"Advances in male contraception","volume":"29","author":"Page","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0015-0282(16)58221-1","article-title":"Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men","volume":"65","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0140-6736(90)92416-F","article-title":"Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib7","first-page":"561","article-title":"Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men","volume":"79","author":"Bagatell","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0010-7824(01)00223-2","article-title":"Testosterone for male contraception during one year: attitudes, well-being and quality of sex life","volume":"64","author":"Sjogren","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1210\/jc.2002-020447","article-title":"A\u00a0multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men","volume":"88","author":"Gu","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib10","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1210\/jc.2008-1846","article-title":"Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men","volume":"94","author":"Gu","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0015-0282(16)57307-5","article-title":"Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility","volume":"63","author":"Handelsman","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/17.6.1490","article-title":"Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men","volume":"17","author":"Kinniburgh","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib13","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/humrep\/17.11.2869","article-title":"Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone","volume":"17","author":"Anderson","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib14","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1210\/jc.2003-030107","article-title":"Contraceptive efficacy of a depot progestin and androgen combination in men","volume":"88","author":"Turner","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib15","first-page":"1244","article-title":"Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception","volume":"84","author":"Buchter","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib16","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1210\/jcem.87.8.8710","article-title":"Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone","volume":"87","author":"Gonzalo","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib17","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1210\/jc.2006-1411","article-title":"Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist","volume":"91","author":"Page","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib18","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1210\/jc.2012-1384","article-title":"A\u00a0new combination of testosterone and nestorone transdermal gels for male hormonal contraception","volume":"97","author":"Ilani","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2006.11.003","article-title":"Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen","volume":"75","author":"Amory","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib20","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(06)68614-5","article-title":"Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis","volume":"367","author":"Liu","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib21","doi-asserted-by":"crossref","first-page":"13692","DOI":"10.1073\/pnas.2232815100","article-title":"The low gonadotropin-independent constitutive production of testicular testosterone is sufficient to maintain spermatogenesis","volume":"100","author":"Zhang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib22","first-page":"757","article-title":"Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach","volume":"81","author":"Bebb","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib23","first-page":"405","article-title":"Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial","volume":"26","author":"Anawalt","year":"2005","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1210\/jc.2002-020918","article-title":"The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone","volume":"88","author":"Herbst","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib25","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/j.1939-4640.2004.tb02846.x","article-title":"Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in Chinese men","volume":"25","author":"Gui","year":"2004","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1210\/jc.2005-1743","article-title":"Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men","volume":"91","author":"Wang","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib27","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1210\/jcem.87.8.8773","article-title":"Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception","volume":"87","author":"Anderson","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/humrep\/dei300","article-title":"A\u00a0multi-centre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive","volume":"21","author":"Brady","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib29","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1210\/jc.2008-0265","article-title":"Male hormonal contraception: a double-blind, placebo-controlled study","volume":"93","author":"Mommers","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib30","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1210\/jc.2004-1852","article-title":"Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate","volume":"90","author":"Meriggiola","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib31","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/jc.2003-031307","article-title":"Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in chinese men","volume":"89","author":"Gu","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib32","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/humrep\/13.5.1225","article-title":"Low dose of cyproterone acetate and testosterone enanthate for contraception in men","volume":"13","author":"Meriggiola","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib33","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1210\/jc.2003-030574","article-title":"Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men","volume":"88","author":"Meriggiola","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib34","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/jc.2007-2768","article-title":"Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis","volume":"93","author":"Liu","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib35","first-page":"3527","article-title":"Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone","volume":"83","author":"Swerdloff","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib36","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/humrep\/16.12.2570","article-title":"Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone","volume":"16","author":"Behre","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00280-009-1038-1","article-title":"Oral administration of the GnRH antagonist acyline, in a GIPET-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics","volume":"64","author":"Amory","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib38","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1210\/jc.2002-021960","article-title":"Evidence for tissue selectivity of the synthetic androgen 7a-methyl-19-nortestosterone in hypogonadal men","volume":"88","author":"Anderson","year":"2003","journal-title":"J\u00a0Clin Endocrinol"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib39","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1210\/jc.2002-022043","article-title":"A\u00a0clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men","volume":"88","author":"von Eckardstein","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib40","first-page":"679","article-title":"7alpha-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men","volume":"28","author":"Walton","year":"2007","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib41","first-page":"530","article-title":"Development of dimethandrolone 17beta-undecanoate (DMAU) as an oral male hormonal contraceptive: induction of infertility and recovery of fertility in adult male rabbits","volume":"32","author":"Attardi","year":"2011","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2605.1998.00092.x","article-title":"Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug","volume":"21","author":"Waites","year":"1998","journal-title":"Int J Androl"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1095\/biolreprod.103.026989","article-title":"The ability of a gonadotropin-releasing hormone antagonist, acyline, to prevent irreversible infertility induced by the indenopyridine, CDB-4022, in adult male rats: the role of testosterone","volume":"71","author":"Hild","year":"2004","journal-title":"Biol Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib44","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1210\/en.2006-1487","article-title":"Development of l-CDB-4022 as a nonsteroidal male oral contraceptive: induction and recovery from severe oligospermia in the adult male cynomolgus monkey (Macaca fascicularis)","volume":"148","author":"Hild","year":"2007","journal-title":"Endocrinology"},{"issue":"Suppl. 2","key":"10.1016\/j.bpobgyn.2014.05.008_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000238044","article-title":"Effects of AF 1312\/TS and lonidamine on cultured sertoli cells","volume":"27","author":"Marcante","year":"1981","journal-title":"Chemotherapy"},{"issue":"Suppl. 2","key":"10.1016\/j.bpobgyn.2014.05.008_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000238043","article-title":"Effects of AF 1312 TS and lonidamine on mammalian testis. A morphological study","volume":"27","author":"De Martino","year":"1981","journal-title":"Chemotherapy"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib47","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1095\/biolreprod64.5.1500","article-title":"Reversible inhibition of spermatogenesis in rats using a new male contraceptive, 1-(2,4-dichlorobenzyl)-indazole-3-carbohydrazide","volume":"64","author":"Grima","year":"2001","journal-title":"Biol Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1530\/REP-10-0464","article-title":"Adjudin, a potential male contraceptive, exerts its effects locally in the seminiferous epithelium of mammalian testes","volume":"141","author":"Mok","year":"2011","journal-title":"Reproduction"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib49","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1095\/biolreprod.106.057810","article-title":"A\u00a0novel potent indazole carboxylic acid derivative blocks spermatogenesis and is contraceptive in rats after a single oral dose","volume":"78","author":"Tash","year":"2008","journal-title":"Biol Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib50","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2012.06.045","article-title":"Small-molecule inhibition of BRDT for male contraception","volume":"150","author":"Matzuk","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib51","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1210\/en.2010-0941","article-title":"Oral administration of a retinoic acid receptor antagonist reversibly inhibits spermatogenesis in mice","volume":"152","author":"Chung","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib52","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/ml300365k","article-title":"Pharmacological activity of retinoic acid receptor alpha-selective antagonists and","volume":"4","author":"Chung","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-008X(61)90002-3","article-title":"Suppression of spermatogenesis and chronic toxicity in men by a new series of bis(dichloroacetyl) diamines","volume":"3","author":"Heller","year":"1961","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib54","first-page":"107","article-title":"Histopathology of the human testes as affected by bis(dichloroacetyl)diamines","volume":"2","author":"Heller","year":"1963","journal-title":"Exp Mol Pathol Suppl"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib55","first-page":"111","article-title":"Suppression of spermatogenesis by bisdichloroacetyldiamines is mediated by inhibition of testicular retinoic acid biosynthesis","volume":"32","author":"Amory","year":"2011","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib56","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1128\/MCB.24.19.8642-8648.2004","article-title":"Targeted deletion of the epididymal receptor HE6 results in fluid dysregulation and male infertility","volume":"24","author":"Davies","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.mce.2005.12.034","article-title":"Epididymal secreted protein Crisp-1 and sperm function","volume":"250","author":"Roberts","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib58","doi-asserted-by":"crossref","first-page":"17173","DOI":"10.1073\/pnas.262586099","article-title":"Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception","volume":"99","author":"van der Spoel","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib59","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/humrep\/del414","article-title":"Miglustat has no apparent effect on spermatogenesis in normal men","volume":"22","author":"Amory","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib60","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1056\/NEJMcibr1001843","article-title":"Sperm and the proton channel","volume":"362","author":"Ren","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib61","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-physiol-020911-153258","article-title":"The control of male fertility by spermatozoan ion channels","volume":"74","author":"Lishko","year":"2012","journal-title":"Ann Rev Physiol"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib62","doi-asserted-by":"crossref","first-page":"16501","DOI":"10.1073\/pnas.0407708101","article-title":"Glyceraldehyde 3-phosphate dehydrogenase-S, a sperm-specific glycolytic enzyme, is required for sperm motility and male fertility","volume":"101","author":"Miki","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1875397301105010030","article-title":"Development and implementation of a high throughput screen for the human sperm-specific isoform of glyceraldehyde 3-phosphate dehydrogenase (GAPDHS)","volume":"5","author":"Sexton","year":"2011","journal-title":"Curr Chem Genomics"},{"key":"10.1016\/j.bpobgyn.2014.05.008_bib64","article-title":"U.N. report says progress for women is unequal","author":"Sengupta","year":"2014","journal-title":"New York Times"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T16:23:55Z","timestamp":1538583835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693414001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1521693414001084"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.05.008","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Male contraception","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}